
The Democratic Republic of Congo (DRC) has reached a grim milestone in its battle against Ebola, with confirmed cases surpassing 11,000. Government data released on Tuesday indicates that the current epidemic is now the deadliest in the country’s history, claiming at least 5,387 lives. Driven by the rare Bundibugyo strain, the crisis has already affected eight provinces, stretching the nation’s healthcare infrastructure to its limits and triggering a state of heightened alertness across the African continent. This current outbreak is now ranked as the second-largest on record globally, trailing only the West African epidemic that occurred between 2014 and 2016. Health authorities report that a significant number of fatalities are occurring outside of specialized treatment centres. This trend is largely attributed to delayed detection of the virus and the immense pressure on existing medical services. The geographical spread of the disease is also causing concern, as cases have been reported across East, Central, and West Africa, prompting calls for urgent international intervention. In response to the escalating crisis, the World Health Organization (WHO) has approved clinical trials for new vaccines. These trials aim to provide more effective protection against the Bundibugyo strain, though final results are not expected until early 2027. Until these medical advancements are available, health experts emphasize that the focus must remain on rapid detection and containment. Regional leaders and international health organizations are being urged to coordinate their efforts to prevent further cross-border transmission and support the DRC’s struggling healthcare system.